Patent US4182859A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4182859A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the preparation of 2'-deoxyribofuranosyl nucleosides

Assignee: Robugen GmbH Pharmaceutische Fabrik
•
Filing: 1978-05-10
•
Granted: 1980-01-08
•
Expires: 1998-05-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 2'-Deoxyribofuranosyl nucleosides having the formula: ##STR1## , wherein R 1 is a hydrogen atom, a straight-chain or branched alkyl group of 1-6 carbon atoms, a phenyl or benzyl group, a methoxy group, a halogen atom, a nitro group, a nitrile group or an amino group which can be mono- or disubstituted by alkyl of 1-6 carbon atoms, or in which the nitrogen atom thereof is part of a 5- or 6-membered ring, or a perfluoroalkyl group of 1-6 carbon atoms; R 2 is a hydrogen atom or a halogen atom; and R 3 and R 4 are benzoyl, tolyl, p-chlorobenzoyl or p-nitrobenzoyl, which comprises reacting a 1-halogen derivative of a blocked 2-deoxy-D-ribose with a silylated pyrimidine derivative in an alkyl nitrile solvent in the presence of a mercury (II) salt at a temperature of about -10° to about 40° C. The biologically active β-anomers can be separated from the resulting reaction mixture readily and in high yield. The disclosed process is particularly suitable as a means for producing the known antiviral compound β-5-ethyl-2'-deoxyuridine.

Inventors

  • 👤 Siegfried Erhardt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 13:14
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 248 words
A process for the preparation of substantially pure β-anomers of 2'-deoxyribofuranosyl nucleosides of the formula: ##STR5## wherein R 1 represents a hydrogen atom, a straight-chain or branched alkyl group of 1 to 6 carbon atoms, a phenyl or benzyl group, a methoxy group, a halogen atom, a nitro group, a nitrile group, or an amino group which is unsubstituted or mono- or disubstituted by alkyl residues of 1 to 6 carbon atoms, or in which the nitrogen atom thereof can be part of a 5- or 6-membered ring, or a perfluoroalkyl group of 1 to 6 carbon atoms; R 2 is a hydrogen atom or a halogen atom; and R 3 and R 4 represents a benzoyl, tolyl, p-chlorobenzoyl, or p-nitrobenzoyl group, which comprises reacting a 1-halogen derivative of a blocked 2-deoxy-D-ribose having the formula: ##STR6## wherein Hal represents a halogen atom, with a silylated pyrimidine derivative having the formula: ##STR7## wherein R 1 , R 2 , R 3 and R 4 have the above-indicated meanings, in an alkyl nitrile solvent having the formula: R.sup.5 --C.tbd.N IV wherein R 5 represents a straight-chain or branched alkyl group of 1 to 4 carbon atoms, and in the presence of a mercury(II) salt at a temperature of about -10° to about +40° C.; precipitating the desired β-anomer as the only insoluble component by allowing the reaction mixture to stand at a temperature of between about -3° C. to 20° C.; and separating the thus-precipitated β-anomer from the reaction mixture.
Claim 2
Dependent Claim 248 words
A process for the preparation of substantially pure β-anomers of 2'-deoxyribofuranosyl nucleosides of the formula: ##STR5## wherein R 1 represents a hydrogen atom, a straight-chain or branched alkyl group of 1 to 6 carbon atoms, a phenyl or benzyl group, a methoxy group, a halogen atom, a nitro group, a nitrile group, or an amino group which is unsubstituted or mono- or disubstituted by alkyl residues of 1 to 6 carbon atoms, or in which the nitrogen atom thereof can be part of a 5- or 6-membered ring, or a perfluoroalkyl group of 1 to 6 carbon atoms; R 2 is a hydrogen atom or a halogen atom; and R 3 and R 4 represents a benzoyl, tolyl, p-chlorobenzoyl, or p-nitrobenzoyl group, which comprises reacting a 1-halogen derivative of a blocked 2-deoxy-D-ribose having the formula: ##STR6## wherein Hal represents a halogen atom, with a silylated pyrimidine derivative having the formula: ##STR7## wherein R 1 , R 2 , R 3 and R 4 have the above-indicated meanings, in an alkyl nitrile solvent having the formula: R.sup.5 --C.tbd.N IV wherein R 5 represents a straight-chain or branched alkyl group of 1 to 4 carbon atoms, and in the presence of a mercury(II) salt at a temperature of about -10° to about +40° C.; precipitating the desired β-anomer as the only insoluble component by allowing the reaction mixture to stand at a temperature of between about -3° C. to 20° C.; and separating the thus-precipitated β-anomer from the reaction mixture.
Claim 3
Dependent Claim 21 words
The process of claim 1, wherein the mercury(II) salt employed is HgBr 2 , and the nitrile solvent employed is acetonitrile.
Claim 4
Dependent Claim 12 words
The process of claim 1, wherein R 1 is an ethyl group.
Claim 5
Dependent Claim 12 words
The process of claim 1, wherein R 1 is a piperidine ring.
Claim 6
Dependent Claim 12 words
The process of claim 1, wherein R 1 is a morpholine ring.
Claim 7
Dependent Claim 13 words
The process of claim 1, wherein R 1 is a CF 3 group.
Claim 8
Dependent Claim 14 words
The process of claim 1, wherein R 2 is a fluorine or chlorine atom.
Claim 9
Dependent Claim 17 words
The process of claim 1, wherein the Hal in said blocked 2-deoxy-D-ribose derivative is a chlorine atom.
Claim 10
Dependent Claim 20 words
The process of claim 1, wherein said nitrile solvent is selected from the group consisting of acetonitrile, propionitrile and butyronitrile.
Claim 11
Dependent Claim 27 words
The process of claim 1, wherein said mercury(II) salt is selected from the group consisting of HgBr 2 , HgCl 2 and Hg(CH 3 COOO) 2 .
Claim 12
Dependent Claim 16 words
The process of claim 1, wherein the β-anomer is separated from the reaction mixture by filtration.
Claim 13
Dependent Claim 21 words
The process of claim 1, wherein the recovered β-anomer is extracted and washed in order to remove any traces of mercury.
Claim 14
Dependent Claim 10 words
The process of claim 1, wherein the β-anomer is 1-[2'-deoxy-3',5'di-O-(p-chlorobenzoyl)-β-D-ribofuranosyl]-5-ethyluracil.

References Cited (Backward Citations)

US3354160A Cited
US3352849A Cited
US3531464A Cited
US3708469A Cited
US3748320A Cited
US3817980A Cited
US4082911A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-01-07 1983-07-09 1984-01-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-01-07 1987-07-09 1988-01-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-01-07 1991-07-09 1992-01-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag